Delivery Order SPE2DB22D2211-SPE2DB25FRWQL

Award Date 5/5/25
Potential Completion Date 5/27/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,360.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product, with a period of performance through December 10, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,138.25, is for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product. The contract has an ultimate completion date of April 24, 2025 and uses a firm fixed price pricing type. This contract award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $1,180.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product, with a completion date of December 4, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,221.00 firm fixed-price delivery order covers the provision of RHOGAM ULTRA-FILTERED PLUS SYRS, a critical medical product, with a performance period through December 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, with a unique identifier of SPE2DB22D3301|SPE2DB24FY7US, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product, with a ceiling value of $2,360.40 and a completion date of June 25, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation mentioned for this award....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,836.04 firm fixed price contract is for the supply of RHOPHYLAC, a 300 mcg/2 mL syringe medication, with an ultimate completion date of October 15, 2024. The award does not utilize a set-aside designation. AmerisourceBergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, collectively valued up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. The contract has a firm fixed price of $1,377.03 and an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,147.20, is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML medical supplies. The contract has an ultimate completion date of May 27, 2025. AmerisourceBergen Drug Corp, a for-profit organization headquartered in Conshohocken, Pennsylvania, is a critical supplier of medical and pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has a ceiling value of $5,052.60 and runs through September 30, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this contract is part of the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a medical product. The contract, valued at $1,380.52, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). The contract has an ultimate completion date of August 14, 2024, and is structured as a Firm Fixed Price Delivery Order. Amerisourcebergen is a well-established federal...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRWQL
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product. The delivery order has a firm fixed price of $1,969.36 and a period of performance through May 27, 2025. This order is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. The IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/10/25, 1:21 AM